Design, Synthesis and Anticancer Activity of New Thiazole-Tetrazole or Triazole Hybrid Glycosides Targeting CDK-2 via Structure-Based Virtual Screening

(E-pub Ahead of Print)

Author(s): Asmaa F. Kassem*, Eman M. H. Abbas, Dina S. El-Kady, Hanem M. Awad, Wael A. El-Sayed*.

Journal Name: Mini-Reviews in Medicinal Chemistry

Become EABM
Become Reviewer

Abstract:

Background & Objective: The target tetrazole glycosides were synthesized by construction of ring system by cycloaddition reaction of benzothiazole-linked nitrile derivative and sodium azide followed by N-glycosylation process and deprotection.

Method & Results: The triazole glycosides were a result of applying click approach involving dipolar cycloaddition of benzothiazole possessing alkyne functionality and different glycosyl azides. The products incorporating acyclic analogs of sugar moieties were synthesized through alkylation using acyclic oxygenated halides. The anticancer activity was studied against human breast adenocarcinoma cells (MCF-7) and human normal Retina pigmented epithelium cells (RPE-1). High activities were revealed by three compounds with IC50 values 11.9-16.5 μM compared to doxorubicin (18.6 μM) in addition to other four derivatives with good inhibition activities.

Conclusion: Enzyme docking investigation was performed into cyclin-dependent kinase 2 (CDK2); a potential target for cancer medication. Compounds which have possessed highest activities revealed good fitting inside the binding site of the protein molecular surface and showed minimum binding energy.

Keywords: Thiazole, tetrazoles, 1, 2, 3-triazoles, glycosides, CDK-2, docking, breast cancer.

Rights & PermissionsPrintExport Cite as


Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1389557519666181231121217
Price: $95